The transfer of lipids across the placenta was measured after infusion of an emulsion of triacylglycerol and phospholipid (Intralipid) into 10 anesthetized rabbits. Maternal and umbilical venous and arterial samples were collected at 10-min intervals. All samples were analyzed for concentration and fatty acid composition of FFA, triacylglycerol, and phospholipid fractions. At the end of the infusion period of Intralipid, there was a significant increase in the maternal concentrations of total triacylglycerol ( p < 0.01) and of total phospholipid ( p = 0.01) but not of total FFA ( p > 0.05). Maternal plasma triacylglycerol and phospholipid altered in composition to match that of the infused Intralipid by the end of the infusion. Despite the significant rise in maternal triacylglycerol and phospholipid concentrations, the umbilical vein-artery difference for these lipid fractions remained unchanged and very low. In contrast, the umbilical vein-artery difference for FFA (p < 0.02) rose gradually throughout the experiments. There was no significant change in the fatty acid composition of the maternal FFA, but the fatty acid composition of the umbilical vein-artery difference for FFA changed to reflect the composition of Intralipid. These experiments show that exogenous triacylglycerol and phospholipid dramatically alter the lipid fractions presented to the placenta in the maternal plasma but do not cross the placenta intact. However, the composition of the FFA crossing the placenta is modulated to become more similar to that of the exogenous lipid. (Pediatr Res 38: 1026-
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Factors related to adult lifestyle, such as diet, smoking, and lack of exercise, have been seen as the major risk factors for ischemic heart disease (1). However, recent epidemiologic evidence has suggested that some of the risk of cardiovascular disease in adulthood is related to fetal growth and infant feeding (2) (3) . Experiments in animals have shown that, after birth, different early feeding regimes can lead to permanent changes in plasma lipid concentrations and in the activity of enzymes controlling cholesterol metabolism (4) (5) (6) . It may be therefore that, earlier in life, fetal nutrition may also program lipid metabolism in adulthood.
One group of infants particularly at risk of cardiovascular mortality in later life are those who suffer from intrauterine growth retardation (3) . At present there are few therapeutic interventions available which improve the fetal growth of these infants (7) . One option is to try to increase placental transfer of nutrients to the fetus by supplementation of maternal nutrition (8) . We have developed the technique of in situ perfusion of the rabbit placenta which allows examination of transfer from mother to fetus under closely controlled conditions (9, 10) . We report a series of experiments in which direct measurements of the transfer of lipids across the placenta were made serially after infusion of an emulsion of triacylglycerol and phospholipid into the mother.
METHODS

Experimental. Ten New Zealand WhitelCalifornian rabbits
were studied at 28-d gestation (term = 31 d). The surgical methods used have been previously described (9) .
Maternal preparation. The doe was placed on a heated Placental preparation. A laparotomy was performed, and one fetus was withdrawn through a longitudinal incision in the uterus and delivered onto the abdomen of the doe. The umbilical arteries and vein were cannulated with 22 gauge and 20 gauge catheters (Argyle Medicut, Sherwood Medical Industries), respectively. The exposed uterus and placenta were kept moist and at body temperature by a radiant heat source and a plastic cover. The uterine temperature was monitored throughout the experiment using a thermocouple.
Perfusion of the placenta. The fetal placental circulation was perfused at 1 mL/min with 4% bovine albumin in Kreb's Henseleit bicarbonate saline (the "perfusate") via both umbilical artery catheters using a peristaltic pump. The perfusate was gassed continuously with 95% 0,/5% CO,, and the pH was adjusted to 7.4 using a Tris combination electrode (pH electrode EL 69B, Waldren Precision Apparatus Ltd, Cambridge) suitable for protein solutions. Infusion of Intralipid. After 20 min of placental perfusion, to allow the preparation to stabilize, baseline FFA, triacylglycerol, and phospholipid concentrations were measured in the perfusate flowing out of the umbilical venous catheter. The same biochemical measurements were made on the artificial perfusate flowing into the umbilical arterial catheters from the reservoir. The difference between the inflowing and outflowing concentrations represents the net lipids added to the umbilical circulation from the placenta. After collection of these baseline samples, an infusion of 5 mL of 20% Intralipid was given i.v. to the doe over 10 min. Further maternal and umbilical venous samples were collected at the end of the infusion period and at 10-min intervals thereafter for the following 40 min.
FFA profiles. A modification of the method described by Elphick et al.
(1 1) was used to measure fatty acid concentrations and composition. A 500-pL sample of plasma or perfusate was extracted into redistilled n-heptane according to the method of Dole (12) . Fatty acid soaps were formed by the addition of 0.015 M sodium hydroxide to the extracted fatty acids. The water-soluble soaps were extracted into an ethanolaqueous phase. To convert the soaps back to the acid form, 0.1 M sulfuric acid was added, and the FFA was extracted into pentane (Distol reagent, Fisons Plc, Loughborough, Leics.). The extract was dried, and boron trifluoride methanol complex (Fisons Plc, Loughborough, Leics.) was added. The tubes were gassed with oxygen-free nitrogen, tightly stoppered, and incubated at 65°C for 10 min. The fatty acid methyl esters so formed were extracted into pentane and separated by gas liquid chromatography as described below. This method allowed measurement of FFA down to 5 X lop4 pmo1/500 p L sample. The reproducibility and precision of the method was found to be 4.8 and 6.7% (coefficient of variation using measurements of 20 replicate analyses).
Triacylglycerol and phospholipid profiles. Lipids were extracted using a modification of the method of Folch et al. (13) . A 1-mL sample of plasma perfusate was added to 20 mL of redistilled chloroform/methanol, 2:1 vol/vol, mixed well, and allowed to stand for 10 min. Intralipid diluted 1:100 in distilled water was similarly extracted. The extracts were washed with 0.1 M phosphate buffer (pH 6.0), and the phases were allowed to separate. The top aqueous phase containing nonlipid constituents was discarded, and the bottom chloroform phase was filtered through fat-free filter paper and washed through with redistilled chloroform/methanol, 2: 1 vol/vol. The lipids in this extract were subjected to thin layer chromatography on plates coated with a 0.4-mm thick layer of Silica Gel H (Merck, BDH Ltd, Poole, Dorset) to separate out the different lipid fractions. The plates were run in tanks in which the atmosphere was equilibrated with a solvent system of hexane:diethyl ether:formic acid, 75:25:1 vol/vol, in oxygen-free nitrogen. The lipid zones were located by spraying the plates with 0.002% rhodamine 6G (Seare, High Wycombe, Bucks) in ethanol containing 1 g/L DL-a-tocopherol (antioxidant) (Sigma Chemical Co. Ltd, Poole, Dorset) under UV light. The phospholipid and triacylglycerol areas were scraped off and subjected to methanolysis.
The method of Glass (14) was used to prepare fatty acid methyl esters from these phospholipids and triacylglycerols. After addition of 500 p L of sodium methoxide reagent (prepared by dissolving 2.3 g of sodium metal (BDH Ltd, Poole, Dorset) in 100 mL of 60% methanolibenzene, vol/vol), the samples were allowed to stand for 10 min, and 1 mL of methanolic hydrochloric acid (10 mL concentrated hydrochloric acid, specific gravity 1.16 made up to 100 mL with methanol), was added. The tubes were shaken and allowed to stand for a further 30 min. The fatty acid methyl esters were extracted into pentane and analyzed by gas liquid chromatography as described below. This method allowed measurement of triacylglycerol and phospholipid fatty acid down to 1 X l o p 3 pmol/mL sample. The reproducibility and precision of the method was found to be 4.9 and 7.1% for phospholipid and 5.9 and 9.0% for triacylglycerol, respectively (coefficient of variation using the measurement of 20 replicate analyses).
Gas liquid chromatography. A Perkin-Elmer gas chromatograph model 8410 fitted with a flame ionization detector was used to separate fatty acid methyl esters. A fused silica capillary column 30 m in length with an internal diameter of 0.32 mm was coated with SP2330 (bicyanopropylphenyl polysiloxane) at a film thickness of 0.2 p m (Supelchem, Saffron Walden, Essex) was used. The column was run isothermally at 185°C with a linear gas velocity of 20 cm/s. The injection and detection temperatures were maintained at 250°C. A split1 splitless injection system was used at a ratio of 70:l. Fatty acids were identified by comparison of their retention times with those of authenticated standards (Sigma Chemical Co.) and were quantified by comparison with an internal standard (heptadecanoic acid for FFA, triheptadecanoin for triacylglycerols, and L-a-phosphatidylcholine diheptadecanoyl for phospholipids).
Antipyrine measurements. Antipyrine concentrations were determined in 1.0-mL perfusate samples deproteinized with zinc hydroxide, followed by the addition of sodium nitrite and spectrophotometric measurement of 4-nitrosoantipyrine (15) .
Statistical methods. Comparisons were made using nonparametric tests because the biochemical data were not normally distributed (Wilcoxon's signed rank test). Rather than make multiple paired comparisons, which are liable to falsely reject STAMMERS ET AL.
the null hypothesis, time-series measurements were subjected to Friedman's two-way analysis of variance. Table 1 shows a number of measures of physiologic stability documented at the beginning and end of each experiment. There was a significant fall in maternal blood pressure and maternal arterial pH over the duration of the experiment but placental antipyrine clearance did not change during the period of study and this suggests that maternal placental blood flow was not altered by these changes in systemic blood pressure and pH. We have previously conducted several series of experiments which use the same anesthesia but did not involve the infusion of Intralipid to the pregnant doe (9, 10, 16, 17) . All of these experiments showed no significant change in maternal blood gases, placental perfusion pressure, and maternal to umbilical antipyrine ratio. Most experiments showed a trend for maternal blood pressure to fall over a similar time course by less than 10%. This change in blood pressure reached statistical significance in two series of experiments (9, 10) . These findings illustrate the general physiologic stability of the preparation. The "cross-over" experimental design used in these studies was chosen because of the inherent variability of animals undergoing anesthesia, and given that there were no significant changes in physiologic variables in the mothers receiving Intralipid, it can be concluded that the Intralipid infusion was not significantly altering the preparation.
RESULTS
Stability of the preparation.
Total plasma lipid concentrations. At the end of the 10-min infusion period of Intralipid, there was a significant increase of total triacylglycerol ( p < 0.01, Wilcoxon's signed rank test) and of total phospholipid (p = 0.01, Wilcoxon's signed rank test) in the maternal circulation (Fig. 1) . Despite the significant rise in maternal triacylglycerol and phospholipid concentrations, the umbilical vein-artery difference for these lipid fractions remained unchanged and very low. There was a significant umbilical vein-artery difference for FFA at all sample times ( p < 0.05). Maternal FFA concentrations rose after the Intralipid infusion (Friedman's two-way analysis of variance, p = 0.0007). This was mirrored by a corresponding rise in perfusate vein-artery difference as can be seen in Figure 1, although not statistically significant ( p > 0.05). Figure 2 shows the individual fatty acid concentrations associated with FFA, triacylglycerol, and ( p < 0.05) acids. These fatty acids represent the major fatty acids of the Intralipid emulsion in the triacylglycerol and phospholipid fractions, respectively (Fig. 3) . The fatty acid composition of the maternal FFA fraction was not altered significantly at the end of the infusion or at any time thereafter up to the final sampling point of 40 min after the infusion. By the end of the infusion period, the only significant changes in concentration in the perfusate vein-artery difference were for C18:2n6 and C18: ln9 ( p < 0.05). These are the main fatty acid components of Intralipid. By 20 min after the end of the infusion, the maximum increase in the vein-artery difference for FFA occurs when compared with the preinfusion vein-artery difference. By this time there were increases in C16:O ( p < 0.05), C18:O (p < 0.01), C18:3n3 ( p < 0.01), and C20:3n6 ( p < 0.05) as well as C18:ln9 ( p = 0.01) and C18:2n6 ( p < 0.01). Because over 90% of the lipid in Intralipid is triacylglycerol, five of these six fatty acids represent the dominant esterified fatty acids within Intralipid (see Fig. 3 ). significantly elevated above pre-Intralipid infusion levels. This time was our last sampling point.
Plasma lipid profiles.
DISCUSSION
There have been previous experiments in animals manipulating maternal diet and examining the effect on fetal lipids (18) (19) (20) . Feeding pregnant rats (21) or rabbits (19) a diet with added corn oil (rich in C18:2n6) led to an increase in the amount of C18:2n6 in fetal tissues. In the guinea pig, supplementing the diet of dams with maize oil or beef tallow (18) altered the composition of fetal fats in that they came to resemble more closely the profile of the maternal diet. Other studies in which the essential fatty acid composition of the maternal diet was altered in rats showed that this resulted in altered fetal brain growth (22) and impaired learning behavior in the offspring (23) . Given that C18:2n6 and other essential fatty acids are major components of structural lipids in the CNS, this sequence of events is consistent with the fact that the mammalian fetus cannot synthesize polyenoic derivatives de novo and is dependent on transplacental flux of essential fatty acids.
Manipulation of the maternal diet has consequences for the development of the lung as well as the brain; altering the relative proportions of saturated and unsaturated fats in the diet of pregnant rats resulted in significant changes in the type of phospholipids present in fetal lung (24) . Phospholipids represent about 70% of surfactant by weight (25) , and changes in composition may alter the protection conferred against the neonatal respiratory distress syndrome.
In the human, there have been fewer studies, presumably because of ethical and cultural restraints, but at least one intervention study has demonstrated that alteration of the fatty acid composition of maternal diet in early gestation altered the fatty acid composition of fetal tissue (26) . There is also some data from mothers given cod liver oil or sesame oil before surgical abortion which suggested that the fatty acids derived from these triacylglycerols may cross the placenta (27) . An observational study has shown higher levels of C20:4 in the cord blood of infants of mothers taking vegetarian diets (20) .
There have been other reports examining the effect of altering lipids in the maternal circulation by infusing a fat emulsion i.v. (28, 29) . An infusion of triacylglycerol emulsion (Intralipid, an emulsion of soya bean oil rich in C18:2 and C18:l) given i.v. to the pregnant rabbit appeared to be hydrolyzed by the placenta, allowing increased amounts of FFA to cross the placenta (28) . Circulating triacylglycerols are bound to very low density lipoproteins and these authors also demonstrated within rabbit placenta the presence of lipoprotein lipase, an enzyme essential for the hydrolysis of circulating triacylglycerols. An infusion of Intralipid into pregnant women resulted in a large umbilical vein-artery difference for FFA and for triacylglycerols at delivery and the profile of cord blood FFA was altered toward that of the i.v. emulsion (29) .
Our experiments differ in that the methodology reported here allowed us to examine changes in transfer across the placenta serially with time after the Intralipid infusion whereas the previous experiments have investigated the effects on fetal body composition or single fetal blood samples.
In this series of experiments a short infusion of an exogenous fat emulsion resulted in a significant alteration in maternal circulating lipids. The fatty acid composition of the triacylglycerol and phospholipid fractions of Intralipid is shown in Figure 3 . The concentration of triacylglycerol in maternal plasma increased significantly as did the phospholipid concentration and the composition of these fractions in maternal plasma reflected more closely that of the infused Intralipid. After termination of the infusion triacylglycerol concentrations in the maternal circulation returned to baseline values more rapidly than did the concentrations of phospholipid. This is in keeping with the shorter half-life of triacylglycerol in the circulation (30) .
The FFA profile of the outflowing perfusate changed in composition to reflect that of the Intralipid emulsion with the appearance of greater concentrations of C18:2n6 and C18: ln9. This change in perfusate fatty acid profile was sustained throughout the remainder of the experiment. This would sug-gest that the composition of fatty acid released by the placenta into the umbilical circulation was influenced by a placental pool of fatty acid. This implies that the placenta has the ability to take up fatty acids hydrolyzed from triacylglycerol and phospholipid in the maternal circulation and release these fatty acids into the fetal circulation. The infusion of Intralipid into the mother is likely to influence the composition of the placental pool of fatty acid derived from these maternal fractions and result in a different mix of fatty acid reaching the fetus. Although the infused triacylglycerol was cleared from the maternal circulation in these experiments relatively quickly, taking less than 10 min in all, the effects of the infusion on placental transfer of fatty acid was more sustained.
In a series of 33 pregnant women undergoing elective cesarean section, the mean maternal plasma FFA concentration was 1.0 mmol/L and the umbilical vein-artery difference for FFA was 0.036 mmol/L (31) . The umbilical venous-arterial differences in FFA concentrations were much smaller than those observed in the in situ rabbit perfusions reported here despite roughly similar maternal concentrations. Although the absolute amounts may be small relative to the rabbit, these may be physiologically significant because of the longer gestation and slower growth rate.
Because decreased transfer of nutrients into the fetus has been documented in many forms of intrauterine growth retardation, there have been attempts to evaluate whether increasing fetal nutrient availability prevents experimental growth retardation in animal models (32, 33) . In the report by De Prins et al. (33) the improved survival rate in the offspring of supplemented rats was not mediated through differences in placental weight, fetal weight, or fetal liver weight, i.e. maternal hyperalimentation did influence fetal outcome but not by simply stimulating gross placental or fetal growth. Extrapolation of these results to other species would be inappropriate except to say that fetal outcome and/or growth can be markedly affected by the plane of maternal nutrition in late gestation, at least after simple experimental ischemic placental failure. There is epidemiologic evidence that some adult diseases may be linked to adverse environmental influences during fetal life (34) . Interventions which modulate the passage of nutrients from mother to fetus may have a role in preventing mortality and morbidity in both the short-and long-term, although this remains controversial (35) .
